Delayed-type hypersensitivity to heparin with tolerance of its intravenous administration.
Irion
R
R
Department of Dermatology, University of Ulm, Germany.
Gall
H
H
Peter
R U
RU
D000328:Adult; D000925:Anticoagulants / Q000008:administration & dosage / Q000009:adverse effects*; D003875:Drug Eruptions / Q000209:etiology*; D004890:Erythema / Q000139:chemically induced; D005260:Female; D006493:Heparin / Q000008:administration & dosage / Q000009:adverse effects*; D006495:Heparin, Low-Molecular-Weight / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000139:chemically induced*; D007271:Injections, Intradermal; D007275:Injections, Intravenous; D007279:Injections, Subcutaneous; D008875:Middle Aged
D000925:Anticoagulants; D006495:Heparin, Low-Molecular-Weight; D006493:Heparin